http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-101725-U
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate | 2015-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-101725-U |
| titleOfInvention | METHOD OF TREATMENT OF RECTAL CANCER PATIENTS |
| abstract | The method of treatment of patients with rectal cancer is to carry out remote gamma irradiation against the background of polyradiomodification and subsequent surgery. Preoperative prolonged course of mid-range remote gamma therapy is conducted against the background of polyradiomodification. Polyradiomodification includes daily oral administration of the fluoro pyrimidine group of fluoro pyrimidines at a dose of 800 mg per day for 2 doses (morning and evening) for patients up to or 1200 mg for 3 doses of patients weighing more. Pre-dose drop injections of the drug L-arginine hydrochloride "Tivortin", which is carried out at a dose of 100 ml for 60 minutes. before each irradiation session with an initial rate of 10 drops / min, which after 20 min. infusions are increased to 30 drops / min. Surgical treatment in the amount of radical surgery is carried out 4-5 weeks after the end of radiation therapy. |
| priorityDate | 2015-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 14.